Aurora Cannabis Inc. (NASDAQ:ACB - Get Free Report) saw a significant growth in short interest in December. As of December 31st, there was short interest totalling 4,520,000 shares, a growth of 5.9% from the December 15th total of 4,270,000 shares. Currently, 8.3% of the shares of the company are short sold. Based on an average trading volume of 930,400 shares, the short-interest ratio is currently 4.9 days.
Hedge Funds Weigh In On Aurora Cannabis
A number of institutional investors have recently modified their holdings of ACB. Cubist Systematic Strategies LLC acquired a new stake in shares of Aurora Cannabis during the second quarter worth $50,000. Toronto Dominion Bank boosted its stake in Aurora Cannabis by 34,356.4% in the 2nd quarter. Toronto Dominion Bank now owns 18,951 shares of the company's stock worth $88,000 after buying an additional 18,896 shares during the last quarter. Mackenzie Financial Corp purchased a new stake in Aurora Cannabis in the 2nd quarter valued at about $113,000. Finally, Tidal Investments LLC increased its stake in shares of Aurora Cannabis by 2.7% during the 3rd quarter. Tidal Investments LLC now owns 1,344,321 shares of the company's stock valued at $7,905,000 after acquiring an additional 34,988 shares during the last quarter. Institutional investors and hedge funds own 47.63% of the company's stock.
Wall Street Analyst Weigh In
Several equities research analysts have recently weighed in on ACB shares. TD Securities upgraded shares of Aurora Cannabis to a "strong-buy" rating in a research note on Thursday, December 12th. TD Cowen assumed coverage on Aurora Cannabis in a report on Wednesday, December 11th. They issued a "buy" rating on the stock.
Read Our Latest Analysis on ACB
Aurora Cannabis Price Performance
Shares of ACB traded down $0.11 during mid-day trading on Friday, reaching $3.85. 776,872 shares of the company's stock were exchanged, compared to its average volume of 609,058. The company has a quick ratio of 1.88, a current ratio of 3.83 and a debt-to-equity ratio of 0.07. Aurora Cannabis has a 52-week low of $2.84 and a 52-week high of $9.35. The company has a market cap of $211.29 million, a price-to-earnings ratio of -5.07 and a beta of 1.86. The company has a 50-day simple moving average of $4.35 and a two-hundred day simple moving average of $5.31.
About Aurora Cannabis
(
Get Free Report)
Aurora Cannabis Inc, together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.
Featured Articles
Before you consider Aurora Cannabis, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aurora Cannabis wasn't on the list.
While Aurora Cannabis currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
